HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME Test (opens in a new window) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sparrow, P. J. Articles by Sivananthan, M. U. Search for Related Content PubMed PubMed Citation Articles by Sparrow, P. J. Articles by Sivananthan, M. U. Related Collections Magnetic Resonance Imaging Cardiac Radiology

MR Imaging of Cardiac Tumors¹

¹ From the British Heart Foundation Cardiac MRI Unit, Room 170, D Floor, Jubilee Wing, The General Infirmary, Leeds LS1 3EX, England. Received August 11, 2004; revision requested November 8 and received December 22; accepted January 3, 2005. All authors have no financial relationships to disclose. P.J.S. supported by a grant from the British Heart Foundation. Address correspondence to M.U.S. (e-mail: gemma.england{at}leedsth.nhs.uk).

Magnetic resonance (MR) imaging is an important tool in the evaluation of cardiac neoplasms. T1-weighted, T2-weighted, and gadolinium-enhanced sequences are used for anatomic definition and tissue characterization, whereas cine gradient-echo imaging is used to assess functional effects. Recent improvements in pulse sequences for cardiac MR imaging have led to superior image quality, with reduced motion artifact and improved signal-to-noise ratio and tissue contrast. Although there is some overlap in the MR imaging appearances of cardiac tumors, particularly of primary malignancies, differences in characteristic locations and features should allow confident differentiation between benign and malignant tumors. Indicators of malignancy at MR imaging are invasive behavior, involvement of the right side of the heart or the pericardium, tissue inhomogeneity, diameter greater than 5 cm, and enhancement after administration of gadolinium contrast material (as a result of higher tissue vascularity). Concomitant pericardial or pleural effusions are rare in benign processes but occur in about 50% of cases of malignant tumors. MR imaging offers improved resolution, a larger field of view, and superior soft-tissue contrast compared with those of echocardiography, suggesting that knowledge of the MR imaging features of cardiac neoplasms is important for accurate diagnosis and management.

© RSNA, 2005

This article has been cited by other articles:

				E. Stephant, M. Barthelet, P.-Y. Leroux, and D. Revel Lipomatous Hypertrophy of the Interventricular Septum: Echocardiography, Cardiac Magnetic Resonance, and Multidetector Computerized Tomography Imaging Circulation, July 22, 2008; 118(4): e71 - e72. [Full Text] [PDF]

				P. B. Rahmanian, J. G. Castillo, J. Sanz, D. H. Adams, and F. Filsoufi Cardiac myxoma: preoperative diagnosis using a multimodal imaging approach and surgical outcome in a large contemporary series Interactive CardioVascular and Thoracic Surgery, August 1, 2007; 6(4): 479 - 483. [Abstract] [Full Text] [PDF]

				A. K. Attili and F. S. Chew Imaging of Cardiac Masses and Myocardial Disease: Self-Assessment Module Am. J. Roentgenol., June 1, 2007; 188(6_Supplement): S21 - S25. [Abstract] [Full Text] [PDF]

				A. K. Attili, R. Gebker, and P. N. Cascade Radiological Reasoning: Right Atrial Mass Am. J. Roentgenol., June 1, 2007; 188(6_Supplement): S26 - S30. [Abstract] [Full Text] [PDF]